IBDEI0A3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4482,1,3,0)
 ;;=3^Pityriasis Rubra Pilaris
 ;;^UTILITY(U,$J,358.3,4482,1,4,0)
 ;;=4^L44.0
 ;;^UTILITY(U,$J,358.3,4482,2)
 ;;=^94729
 ;;^UTILITY(U,$J,358.3,4483,0)
 ;;=L29.0^^21^279^31
 ;;^UTILITY(U,$J,358.3,4483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4483,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,4483,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,4483,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,4484,0)
 ;;=L29.1^^21^279^33
 ;;^UTILITY(U,$J,358.3,4484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4484,1,3,0)
 ;;=3^Pruritus Scroti
 ;;^UTILITY(U,$J,358.3,4484,1,4,0)
 ;;=4^L29.1
 ;;^UTILITY(U,$J,358.3,4484,2)
 ;;=^5009150
 ;;^UTILITY(U,$J,358.3,4485,0)
 ;;=L29.2^^21^279^34
 ;;^UTILITY(U,$J,358.3,4485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4485,1,3,0)
 ;;=3^Pruritus Vulvae
 ;;^UTILITY(U,$J,358.3,4485,1,4,0)
 ;;=4^L29.2
 ;;^UTILITY(U,$J,358.3,4485,2)
 ;;=^100075
 ;;^UTILITY(U,$J,358.3,4486,0)
 ;;=L29.3^^21^279^35
 ;;^UTILITY(U,$J,358.3,4486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4486,1,3,0)
 ;;=3^Pruritus,Anogenital,Unspec
 ;;^UTILITY(U,$J,358.3,4486,1,4,0)
 ;;=4^L29.3
 ;;^UTILITY(U,$J,358.3,4486,2)
 ;;=^5009151
 ;;^UTILITY(U,$J,358.3,4487,0)
 ;;=L29.9^^21^279^36
 ;;^UTILITY(U,$J,358.3,4487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4487,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,4487,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,4487,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,4488,0)
 ;;=L40.0^^21^279^40
 ;;^UTILITY(U,$J,358.3,4488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4488,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,4488,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,4488,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,4489,0)
 ;;=L40.3^^21^279^42
 ;;^UTILITY(U,$J,358.3,4489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4489,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,4489,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,4489,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,4490,0)
 ;;=L40.4^^21^279^41
 ;;^UTILITY(U,$J,358.3,4490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4490,1,3,0)
 ;;=3^Psoriasis,Guttate
 ;;^UTILITY(U,$J,358.3,4490,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,4490,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,4491,0)
 ;;=L40.8^^21^279^39
 ;;^UTILITY(U,$J,358.3,4491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4491,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,4491,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,4491,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,4492,0)
 ;;=L89.95^^21^279^29
 ;;^UTILITY(U,$J,358.3,4492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4492,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Unstageable (Covered by Eschar)
 ;;^UTILITY(U,$J,358.3,4492,1,4,0)
 ;;=4^L89.95
 ;;^UTILITY(U,$J,358.3,4492,2)
 ;;=^5133660
 ;;^UTILITY(U,$J,358.3,4493,0)
 ;;=L89.92^^21^279^25
 ;;^UTILITY(U,$J,358.3,4493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4493,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 2
 ;;^UTILITY(U,$J,358.3,4493,1,4,0)
 ;;=4^L89.92
 ;;^UTILITY(U,$J,358.3,4493,2)
 ;;=^5133667
 ;;^UTILITY(U,$J,358.3,4494,0)
 ;;=L89.93^^21^279^26
 ;;^UTILITY(U,$J,358.3,4494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4494,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 3
 ;;^UTILITY(U,$J,358.3,4494,1,4,0)
 ;;=4^L89.93
 ;;^UTILITY(U,$J,358.3,4494,2)
 ;;=^5133668
 ;;^UTILITY(U,$J,358.3,4495,0)
 ;;=L89.94^^21^279^27
 ;;^UTILITY(U,$J,358.3,4495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4495,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 4
 ;;^UTILITY(U,$J,358.3,4495,1,4,0)
 ;;=4^L89.94
 ;;^UTILITY(U,$J,358.3,4495,2)
 ;;=^5133669
 ;;^UTILITY(U,$J,358.3,4496,0)
 ;;=L89.90^^21^279^28
